Company Data

Enveric Biosciences Inc.

Ticker
ENVB
Current Price
$1.36 -0.73%
Market Cap
$941.9K
Price Target
Refer to Report
Volume
203.1K
52wk Range
$1.26 - $43.8
Advanced Market Data

Overview

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy